Wells Fargo’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-15,384
| Closed | -$2K | – | 6788 |
|
|
2019
Q4 | $2K | Hold |
15,384
| – | – | ﹤0.01% | 5792 |
|
|
2019
Q3 | $2K | Hold |
15,384
| – | – | ﹤0.01% | 5776 |
|
|
2019
Q2 | $2K | Hold |
15,384
| – | – | ﹤0.01% | 5749 |
|
|
2019
Q1 | $3K | Sell |
15,384
-114,678
| -88% | -$22.4K | ﹤0.01% | 5685 |
|
|
2018
Q4 | $91K | Sell |
130,062
-600
| -0.5% | -$420 | ﹤0.01% | 5087 |
|
|
2018
Q3 | $161K | Hold |
130,662
| – | – | ﹤0.01% | 4924 |
|
|
2018
Q2 | $145K | Hold |
130,662
| – | – | ﹤0.01% | 4991 |
|
|
2018
Q1 | $263K | Sell |
130,662
-13,500
| -9% | -$27.2K | ﹤0.01% | 4663 |
|
|
2017
Q4 | $172K | Buy |
144,162
+13,500
| +10% | +$16.1K | ﹤0.01% | 4851 |
|
|
2017
Q3 | $165K | Buy |
130,662
+106,178
| +434% | +$134K | ﹤0.01% | 4830 |
|
|
2017
Q2 | $32K | Sell |
24,484
-21,886
| -47% | -$28.6K | ﹤0.01% | 5228 |
|
|
2017
Q1 | $86K | Buy |
46,370
+23,316
| +101% | +$43.2K | ﹤0.01% | 5012 |
|
|
2016
Q4 | $119K | Buy |
23,054
+9,709
| +73% | +$50.1K | ﹤0.01% | 4847 |
|
|
2016
Q3 | $74K | Sell |
13,345
-750
| -5% | -$4.16K | ﹤0.01% | 4877 |
|
|
2016
Q2 | $78K | Sell |
14,095
-409
| -3% | -$2.26K | ﹤0.01% | 4780 |
|
|
2016
Q1 | $64K | Buy |
14,504
+308
| +2% | +$1.36K | ﹤0.01% | 4933 |
|
|
2015
Q4 | $85K | Buy |
14,196
+12,255
| +631% | +$73.4K | ﹤0.01% | 4845 |
|
|
2015
Q3 | $15K | Sell |
1,941
-751
| -28% | -$5.8K | ﹤0.01% | 5368 |
|
|
2015
Q2 | $16K | Buy |
2,692
+842
| +46% | +$5K | ﹤0.01% | 5445 |
|
|
2015
Q1 | $15K | Sell |
1,850
-5,250
| -74% | -$42.6K | ﹤0.01% | 5286 |
|
|
2014
Q4 | $36K | Sell |
7,100
-500
| -7% | -$2.54K | ﹤0.01% | 4955 |
|
|
2014
Q3 | $39K | Sell |
7,600
-500
| -6% | -$2.57K | ﹤0.01% | 4885 |
|
|
2014
Q2 | $63K | Buy |
8,100
+3,000
| +59% | +$23.3K | ﹤0.01% | 4761 |
|
|
2014
Q1 | $36K | Buy |
+5,100
| New | +$36K | ﹤0.01% | 4913 |
|